The FDA's Ban of Therapeutic Peptides: A Threat to Health Freedom Slim 'n Sleek The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with How did BPC 157 become the wellness industry's star peptide?